DOI:
10.1055/s-00000071
Seminars in Neurology
LinksClose Window
References
Kappos L, Bar-Or A, Cree BAC. , et al.
Siponimod versus placebo in secondary progressive multiple sclerosis (EXPAND): A double blind, randomised, phase 3 study.
Lancet 2018;
391: 1263-1273
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.